IIT Kanpur signs MOA with Laurus Labs for novel gene therapy assets
IIT Kanpur will transfer several gene therapy assets through in-licensing to Laurus Labs, who will provide a research grant to…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Laurus Labs
Laurus gets tentative USFDA nod for paediatric ARV oral dispersible film drug, Dolutegravir 5mg and…
This paediatric drug administration through Oral Dispersible Film technology developed by Laurus Labs will simplify the drug…
Great Place To Work India announces India’s Best Workplaces in Pharmaceuticals, Healthcare and…
This year, 15 winners have been chosen
Laurus Labs, Unitaid and Clinton Health Access Initiative announce agreement to accelerate second-…
Laurus Labs announced that the development is underway based on an agreement launched in June 2021
Laurus Labs gets DRDO nod to make and market 2-Deoxy-D-glucose (2DG) in India
Laurus has applied with CDSCO for EUA of the drug
Laurus Labs promoters sell 52 lakh equity shares at aggregate Rs 191.67 crores
Significant part of the above amount shall be utilised to release the pledge on their equity shares of the company.
Laurus Labs wins Golden Peacock Award for Excellence in Corporate Governance
This is the first year that Laurus Labs has won this award, instituted in 1991 by the Institute of Directors (IOD), India
Laurus Labs forays into biotech, acquires majority stake in Richcore Lifesciences
Laurus Labs to acquire 72.55 per cent of Richcore’s shares for a value of Rs 246.7 crores
Himachal Pradesh invites industry to sign MoU to set up units in proposed bulk drug park at Una
The State has identified 1,400 acres of land in Una for the bulk drug park and is promising competitive prices for land, power,…
Laurus Labs receives USFDA approvals for two ANDAs under PEPFAR
These approvals enable Laurus Labs to launch both the products in several LMIC markets